These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27466297)

  • 21. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease.
    Alsebaey A; Elhelbawy M; Waked I
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):207-211. PubMed ID: 29240565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.
    Lin ZH; Xin YN; Dong QJ; Wang Q; Jiang XJ; Zhan SH; Sun Y; Xuan SY
    Hepatology; 2011 Mar; 53(3):726-36. PubMed ID: 21319189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
    Deghady A; Abdou A; El-Neanaey WA; Diab I
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.
    Silva Junior RG; Schmillevitch J; Nascimento Mde F; Miranda ML; Brant PE; Schulz PO; Vieira A; Szutan LA
    Scand J Gastroenterol; 2014 Aug; 49(8):986-92. PubMed ID: 24742130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C.
    Fabris C; Smirne C; Toniutto P; Colletta C; Rapetti R; Minisini R; Falleti E; Leutner M; Pirisi M
    Clin Chem Lab Med; 2008; 46(2):253-9. PubMed ID: 18324909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet activation in patients with chronic hepatitis C.
    Fusegawa H; Shiraishi K; Ogasawara F; Shimizu M; Haruki Y; Miyachi H; Matsuzaki S; Ando Y
    Tokai J Exp Clin Med; 2002 Dec; 27(4):101-6. PubMed ID: 12713014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study.
    El-Mezayen HA; Habib S; Marzok HF; Saad MH
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):378-85. PubMed ID: 25874509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive models for predicting histology in patients with chronic hepatitis B.
    Wai CT; Cheng CL; Wee A; Dan YY; Chan E; Chua W; Mak B; Oo AM; Lim SG
    Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
    El Raziky M; Attia D; El Akel W; Shaker O; Khatab H; Abdo S; Elsharkawy A; Esmat G
    Arab J Gastroenterol; 2013 Sep; 14(3):94-8. PubMed ID: 24206736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
    Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
    Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma sphingolipids: potential biomarkers for severe hepatic fibrosis in chronic hepatitis C.
    Li JF; Qu F; Zheng SJ; Ren F; Wu HL; Liu M; Ren JY; Chen Y; Duan ZP; Zhang JL
    Mol Med Rep; 2015 Jul; 12(1):323-30. PubMed ID: 25695872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis.
    Biyik M; Ucar R; Solak Y; Gungor G; Polat I; Gaipov A; Cakir OO; Ataseven H; Demir A; Turk S; Polat H
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):435-41. PubMed ID: 23249602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between indirect bilirubin levels and liver fibrosis due to chronic hepatitis C virus infection.
    Cengiz M; Yılmaz G; Ozenirler S
    Pathol Res Pract; 2014 Aug; 210(8):488-93. PubMed ID: 24842533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
    Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C.
    Koda M; Matunaga Y; Kawakami M; Kishimoto Y; Suou T; Murawaki Y
    Hepatology; 2007 Feb; 45(2):297-306. PubMed ID: 17256741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.